These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16405108)

  • 21. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
    Hauck C; Frishman WH
    Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational states of the pig kidney Na
    Azalim P; do Monte FM; Rendeiro MM; Liu X; O'Doherty GA; Fontes CF; Leitão SG; Quintas LEM; Noël F
    Biochem Pharmacol; 2020 Jan; 171():113679. PubMed ID: 31669257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.
    Anderson DE; Fedorova OV; Morrell CH; Longo DL; Kashkin VA; Metzler JD; Bagrov AY; Lakatta EG
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1248-54. PubMed ID: 18287222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardenolide and bufadienolide ligands of the sodium pump. How they work together in NaCl sensitive hypertension.
    Bagrov AY; Fedorova OV
    Front Biosci; 2005 Sep; 10():2250-6. PubMed ID: 15970491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.
    Bagrov AY; Fedorova OV; Dmitrieva RI; Howald WN; Hunter AP; Kuznetsova EA; Shpen VM
    Hypertension; 1998 May; 31(5):1097-103. PubMed ID: 9576120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous marinobufagenin-like factor in acute plasma volume expansion.
    Fedorova OV; Doris PA; Bagrov AY
    Clin Exp Hypertens; 1998; 20(5-6):581-91. PubMed ID: 9682914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of hypertension.
    Haddy FJ
    N Engl J Med; 2007 Aug; 357(8):827-9; author reply 827-9. PubMed ID: 17715419
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
    Paczula A; Więcek A; Piecha G
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic candidates for EDLF. Activity on human placenta digitalis receptors.
    Paci A; Sakakibara M; Del Bene P; Uchida AO
    Ann N Y Acad Sci; 1997 Nov; 834():637-41. PubMed ID: 9405878
    [No Abstract]   [Full Text] [Related]  

  • 33. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of hypertension.
    Epstein FH
    N Engl J Med; 2007 Aug; 357(8):827-9; author reply 827-9. PubMed ID: 17717863
    [No Abstract]   [Full Text] [Related]  

  • 35. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
    Balzan S; Montali U; Biver P; Ghione S
    J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
    [No Abstract]   [Full Text] [Related]  

  • 36. Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysate.
    Tao QF; Hollenberg NK; Price DA; Graves SW
    Hypertension; 1997 Mar; 29(3):815-21. PubMed ID: 9052901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of the alpha2-isoform of Na+, K(+)-ATPase in the positive inotropic effect of ouabain and marinobufagenin in the rat diaphragm].
    Krivoĭ II; Drabkina TM; Kravtsova VV; Vasil'ev AN; Vashchinkina EV; Prokof'ev AV; Kubasov IV
    Biofizika; 2006; 51(5):906-11. PubMed ID: 17131832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY; Roukoyatkina NI; Pinaev AG; Dmitrieva RI; Fedorova OV
    Eur J Pharmacol; 1995 Feb; 274(1-3):151-8. PubMed ID: 7768267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous digitalis-like ligands of the sodium pump: possible involvement in mood control and ethanol addiction.
    Bagrov AY; Bagrov YY; Fedorova OV; Kashkin VA; Patkina NA; Zvartau EE
    Eur Neuropsychopharmacol; 2002 Feb; 12(1):1-12. PubMed ID: 11788235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor.
    Balzan S; D'Urso G; Nicolini G; Forini F; Pellegrino M; Montali U
    Cell Biochem Funct; 2007; 25(3):297-303. PubMed ID: 17191274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.